Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report

por Ende, Alexander R., Kim, Nina H., Yeh, Matthew M., Harper, Jason, Landis, Charles S.
Publicado 2015

2220. Wirelessly Observed Therapy with a Digital Medicines Program to Optimize Adherence and Target Interventions for Oral Hepatitis C Treatment

por Bonacini, Maurizio, Kim, Yoona, Pitney, Caroline, McKoin, Lee, Tran, Melody, Landis, Charles
Publicado 2018

Wirelessly Observed Therapy to Optimize Adherence and Target Interventions for Oral Hepatitis C Treatment: Observational Pilot Study

por Bonacini, Maurizio, Kim, Yoona, Pitney, Caroline, McKoin, Lee, Tran, Melody, Landis, Charles
Publicado 2020

Sofosbuvir‐based regimens for the treatment of chronic hepatitis C in severe renal dysfunction

por Cox‐North, Paula, Hawkins, Kelsey L., Rossiter, Sean T., Hawley, Marie N., Bhattacharya, Renuka, Landis, Charles S.
Publicado 2017

Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals

por Yilma, Mignote, Kim, Nicole J., Shui, Amy M., Tana, Michele, Landis, Charles, Chen, Ariana, Bangaru, Saroja, Mehta, Neil, Zhou, Kali
Publicado 2023

High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection

por Poordad, Fred, Landis, Charles S., Asatryan, Armen, Jackson, Daniel F., Ng, Teresa I., Fu, Bo, Lin, Chih‐Wei, Yao, Betty, Kort, Jens
Publicado 2016

Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis

por Ioannou, George N., Landis, Charles S., Jin, Ga‐Young, Haigh, W. Geoffrey, Farrell, Geoffrey C., Kuver, Rahul, Lee, Sum P., Savard, Christopher
Publicado 2019

Rapid detection of hepatitis C virus using recombinase polymerase amplification

por Chia, Catherine T., Bender, Andrew T., Lillis, Lorraine, Sullivan, Benjamin P., Martin, Coleman D., Burke, Wynn, Landis, Charles, Boyle, David S., Posner, Jonathan D.
Publicado 2022

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

por Poordad, Fred, Schiff, Eugene R., Vierling, John M., Landis, Charles, Fontana, Robert J., Yang, Rong, McPhee, Fiona, Hughes, Eric A., Noviello, Stephanie, Swenson, Eugene S.
Publicado 2016

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis

por Flamm, Steven, Lawitz, Eric, Borg, Brian, Charlton, Michael, Landis, Charles, Reddy, K. Rajender, Shiffman, Mitchell, Alsina, Angel, Chang, Charissa, Ravendhran, Natarajan, Hernandez, Candido, Hézode, Christophe, Scherbakovsky, Stacey, Mercier, Renee-Claude, Samuel, Didier
Publicado 2023

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment

por Poordad, Fred, Felizarta, Franco, Asatryan, Armen, Sulkowski, Mark S., Reindollar, Robert W., Landis, Charles S., Gordon, Stuart C., Flamm, Steven L., Fried, Michael W., Bernstein, David E., Lin, Chih‐Wei, Liu, Ran, Lovell, Sandra S., Ng, Teresa I., Kort, Jens, Mensa, Federico J.
Publicado 2017

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

por Trauner, Michael, Gulamhusein, Aliya, Hameed, Bilal, Caldwell, Stephen, Shiffman, Mitchell L., Landis, Charles, Eksteen, Bertus, Agarwal, Kosh, Muir, Andrew, Rushbrook, Simon, Lu, Xiaomin, Xu, Jun, Chuang, Jen‐Chieh, Billin, Andrew N., Li, Georgia, Chung, Chuhan, Subramanian, G. Mani, Myers, Robert P., Bowlus, Christopher L., Kowdley, Kris V.
Publicado 2019

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR

por Yeh, Ming-Lun, Liang, Po-Cheng, Tsai, Pei-Chien, Wang, Shu-Chi, Leong, Jennifer, Ogawa, Eiichi, Jun, Dae Won, Tseng, Cheng-Hao, Landis, Charles, Tanaka, Yasuhito, Huang, Chung-Feng, Hayashi, Jun, Hsu, Yao-Chun, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Nguyen, Mindie H., Yu, Ming-Lung
Publicado 2021

Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

por Thompson, Julie, Jones, Natasha, Al‐Khafaji, Ali, Malik, Shahid, Reich, David, Munoz, Santiago, MacNicholas, Ross, Hassanein, Tarek, Teperman, Lewis, Stein, Lance, Duarte‐Rojo, Andrés, Malik, Raza, Adhami, Talal, Asrani, Sumeet, Shah, Nikunj, Gaglio, Paul, Duddempudi, Anupama, Borg, Brian, Jalan, Rajiv, Brown, Robert, Patton, Heather, Satoskar, Rohit, Rossi, Simona, Parikh, Amay, ElSharkawy, Ahmed, Mantry, Parvez, Sher, Linda, Wolf, David, Hart, Marquis, Landis, Charles, Wigg, Alan, Habib, Shahid, McCaughan, Geoffrey, Colquhoun, Steven, Henry, Alyssa, Bedard, Patricia, Landeen, Lee, Millis, Michael, Ashley, Robert, Frank, William, Henry, Andrew, Stange, Jan, Subramanian, Ram
Publicado 2018